Member Info for Wiggly

PL75,

AVCT may perform well, however willing to bet with you that CHF (Chesterfield Resources) will outperform between now and year end.

The programme exploring for Copper and GOLD continues apace!!

Those looking in better take a position soon. If big news drop I think it will be impossible to buy.

DOH - answer the questions then please. 1 more time so that I am clear.

The situation here should be crystal clear and it is not, IMO, hence lots of questions.

Not aligning myself with anyone however (and believe me, he used to wind me up), AW has called it right so far - we are approaching October and no sign of product launch for either BAMS or LFT. I now pay more attention to him than some others....

In response to the answers;

Bams - we're waiting for condor. We've finally seen some movement so hopefully things are starting to happen.

Why are we waiting on CONDUR? On June 9th, we were informed via RNS that Adeptrix were to begin testing with patient samples at a site in the US, and we were told we would be doing the same VERY soon in the UK. As ~4 months have past, are we to believe that Adeptrix have not yet tested with any patient samples in the US?

LFD - we're waiting for tech transfer. Then we'll have to wait for Condor.

On August 7th, we were advised via RNS that AVCT and LSTM would collaborate to CLINICALLY VALIDATE the LFD and that this would be in ADDITION to working with the UK CONDOR programme. I don't believe an NDA would prohibit AVCT from updating the market to say that we do have S&S via LSTM however we cannot disclose until the CONDOR programme completes assessment, in line with NDA.

Medusa - who gives a sh.t.

I do, in my view, it doesn't make sense for this deal to have concluded when it did. Was this pre placement?????

Ava6000 - Q1 but with more Covid fun over the winter we might see it pushed further.

I would still be hopeful of Q4.

Above is not a deramp and Id welcome anyone's thoughts.

Time to face reality.

BAMS? very strange radio silence on this one.

LFT s&s data?? Lstm received at same time they received the ELISA. Why then did we get some data related to the elisa but nothing related to the LFD? Can anyone explain this? The LFD certainly should have been the priority. Are we sitting on this DATA or have the Lstm not yet tested? If they have not yet tested is that because they are awaiting prototype devices? Lots of questions.

Also, I am sorry, but imo, the agreement with Medusa looks ridiculous in hindsight. Sir Al should explain this one.

Also, shouldn't we have heard more about avav6000 by now??

Highly likely....

Continuing to rise. What a time to be drilling a high potential asset! I still cannot believe the lack of action with CHF!

We must be well underway now. Any chance we may get a status update covering the Diamond drill progress (cores extracted perhaps) and/or update on further VMS discoveries related to the Percussion drills?

145

Says the technology for mass, rapid testing is "not yet there".

https://www.google.com/amp/s/www.independent.co.uk/news/health/coronavirus-test-moonshot-nhs-charge-dido-harding-b519895.html%3famp

People with no coronavirus symptoms will have to pay for 'Operation Moonshot' tests, the head of the government's testing programme has said.

Dido Harding told a meeting of business leaders that not all the proposed 15-minute checks would be made available for free on the NHS.

Suggests no multi million contract is forthcoming.

Seems that the UK gov now expect business to pay for the Moonshot!

This current gov is a joke!

Why no update??

The last update on BAMS was 4 months ago!!

The Lstm received the LFD at the same time as the ELISA. Why have we had news on ELISA performance but nothing related to the LFD??????

If we get a placing..

yes, correct. Same logic though, should be the hottest stock on the LSE!

Bang in the middle of a huge drill campaign, CHF should be one of the hottest stocks on AIM!!! Perhaps the calm before the storm!

The Evelyn target, which was tested with the Percussion drill, encountered SIGNIFCANT Sulphide mineralisation. The objective of the active Diamond Drill is to test grade and scale at the Evelyn target and others within the licence.

The CHF exploration team consists of very senior individuals. Neil Obrien was head of exploration at Lundin and Dave Cliff was head of exploration at RIO TINTO!! This is rather unusual for such big hitters to be with a micro cap. Additionally, both are also invested in CHF!

While not a TA expert, I have read the chart suggests clear skies to 15p however, TA/chart aside, what does confirmation of high Grade and Scale do for the share price from this low level?

Also note that Percussion drills can be complete within <1 day. We currently have active percussion drilling, Diamond drilling and AMT surveying all taking place at same time, since Tuesday. We could have market news prior to the conference call.

Exciting times ahead.

All indications per the recent updates look positive.....and the fact they raised cash so quickly to fast track the diamond drilling is also positive.

Looking forward this this. Neil Obrien will give an overview of the current drill programme and I hope a greater insight into the size of the prize here. At a £6.2m MC, any success (which according to the Percussion drill results is very likely - see posts below) should this a significant increase in share price.

Does this suggest that tech transfer has not yet started?

I am sure we all agree, it would be great for AVCT to share a detailed timeline as to when they expect sales to commence, including an update on BAMS and the LSTM S&S numbers covering the LFD. The 'by summer' 'soon' 'very soon' 'shortly' no longer cut it.

This is a reasonable expectation at this point.